ANKRD11-ERGIC2 Fusion FISH Probe
The ANKRD11-ERGIC2 Fusion FISH Probe is used to confirm a fusion of the ANKRD11 and ERGIC2 genes. The fusion of the ANKRD11 and ERGIC2 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ANKRD11-ERGIC2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ANKRD11-ERGIC2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ANKRD11 Gene Summary
This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
Gene Name: Ankyrin Repeat Domain 11
Chromosome: CHR16: 89334034 -89556969
Locus: 16q24.3
ERGIC2 Gene Summary
ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).[supplied by OMIM, Aug 2008]
Gene Name: ERGIC And Golgi 2
Chromosome: CHR12: 29493578 -29534143
Locus: 12p11.22
Gene Diseases
The ANKRD11 ERGIC2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|